We are live on ! Find out more
IMVT icon

Immunovant
IMVT

215 hedge funds and large institutions have $2.75B invested in Immunovant in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 40 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

619% more call options, than puts

Call options by funds: $61.3M | Put options by funds: $8.52M

133% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 40

92% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 24

10% more funds holding

Funds holding: 196 → 215 (+19)

1% less capital invested

Capital invested by funds: $2.76B → $2.75B (-$14.3M)

7.63% less ownership

Funds ownership: 61.96% → 54.34% (-7.6%)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
215
Holders Change
+19
Holders Change %
+9.69%
% of All Funds
2.65%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.09%
New
46
Increased
93
Reduced
40
Closed
24
Calls
$61.3M
Puts
$8.52M
Net Calls
+$52.8M
Net Calls Change
+$26.3M

Top Buyers

1
TCM
TCG Crossover Management
California
+$72.4M
2
Jennison Associates
Jennison Associates
New York
+$64.6M
3
FCM
Farallon Capital Management
California
+$39.7M
4
State Street
State Street
Massachusetts
+$19.4M
5
Bank of America
Bank of America
North Carolina
+$15M

Top Sellers

1
AC
Armistice Capital
New York
-$56.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$50.8M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$37.5M
4
Morgan Stanley
Morgan Stanley
New York
-$25.1M
5
SCM
Soleus Capital Management
Connecticut
-$22.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
PM
51
Prosight Management
Texas
$4.37M -$1.75M -67,579 -28%
Marshall Wace
52
Marshall Wace
United Kingdom
$4.11M +$4.28M +165,300 New
Swiss National Bank
53
Swiss National Bank
Switzerland
$3.96M +$28.5K +1,100 +0.7%
DCM
54
DAFNA Capital Management
California
$3.74M – – –
Citadel Advisors
55
Citadel Advisors
Florida
$3.59M -$262K -10,109 -7%
UBS AM
56
UBS AM
Illinois
$3.52M +$189K +7,287 +5%
EAM
57
Erste Asset Management
Austria
$3.4M +$414K +16,000 +12%
Rafferty Asset Management
58
Rafferty Asset Management
New York
$3.39M +$111K +4,273 +3%
TD Asset Management
59
TD Asset Management
Ontario, Canada
$3.26M -$2.42M -93,608 -42%
NAMI
60
Nomura Asset Management International
Pennsylvania
$3.03M – – –
Blackstone Inc
61
Blackstone Inc
New York
$2.67M +$715K +27,624 +35%
AG
62
Algert Global
California
$2.63M +$2.74M +105,770 New
AAA
63
Affinity Asset Advisors
New York
$2.48M -$2.59M -100,000 -50%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$2.42M +$276K +10,646 +12%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$2.34M +$216K +8,334 +10%
Invesco
66
Invesco
Georgia
$2.33M +$130K +5,037 +6%
DCM
67
DME Capital Management
New York
$2.32M +$2.42M +93,520 New
AllianceBernstein
68
AllianceBernstein
Tennessee
$2.3M +$32.4K +1,250 +1%
JP Morgan Chase
69
JP Morgan Chase
New York
$2.28M +$441K +17,016 +21%
HWAM
70
Hennion & Walsh Asset Management
New Jersey
$2.26M +$500K +19,304 +27%
BPC
71
Banque Pictet & Cie
Switzerland
$2.2M -$679K -26,221 -23%
Jane Street
72
Jane Street
New York
$2.09M +$2.18M +84,312 New
Deutsche Bank
73
Deutsche Bank
Germany
$1.96M +$428K +16,542 +26%
Legal & General Group
74
Legal & General Group
United Kingdom
$1.85M -$473K -18,258 -20%
GCP
75
GSA Capital Partners
United Kingdom
$1.81M +$743K +28,680 +65%
1 2
3
4 5

IMVT Hedge Fund Activity: Q1 2026 in Review

215 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q1 2026, worth a combined $2.75B — down 0.52% from $2.76B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IMVT positions and 24 closed out — a net gain of 22 holders — while 93 added to existing stakes and 40 trimmed.

The largest buyer was TCG Crossover Management, adding an estimated $72.4M. The largest seller was Armistice Capital, cutting an estimated $56.5M.

  • 215 institutional investors held Immunovant (IMVT) as of Q1 2026, up from 196 in Q4 2025.
  • Funds reported $2.75B of Immunovant stock for Q1 2026, down 0.52% quarter-over-quarter.
  • 46 funds opened new Immunovant positions in Q1 2026 and 24 closed out, a net change of +22 holders.
  • The largest Immunovant buyer in Q1 2026 was TCG Crossover Management, an estimated $72.4M added.
  • The largest Immunovant seller in Q1 2026 was Armistice Capital, an estimated $56.5M sold.

Based on aggregated 13F filings for Q1 2026.